Skip to main content
Clinical Trials/NCT00636324
NCT00636324
Terminated
Phase 2

Nasal Continuous Positive Airway Pressure in Preterm Infants After Extubation: Comparison of Different Levels of Pressure

Hamilton Health Sciences Corporation0 sites23 target enrollmentJuly 2007

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Respiratory Insufficiency of Prematurity
Sponsor
Hamilton Health Sciences Corporation
Enrollment
23
Primary Endpoint
The rate of successful extubation within 72 hours of extubation
Status
Terminated
Last Updated
17 years ago

Overview

Brief Summary

Despite widely used of nasal CPAP in preterm infants, uncertainties regarding aspects of its application remain. Clinical indications vary greatly between institutions, especially when combined with varieties of systems, devices, and techniques available. One of the controversial aspects that needs to be clarified is the level of pressure which should be used. The objective of the study is to compare the effectiveness of two ranges of nCPAP pressure that are within the spectrum of current practice for post-extubation support in very preterm infants.

Detailed Description

The use of nCPAP has been established as an effective respiratory support to prevent extubation failure and as treatment of other pulmonary diseases. An upsurge in its popularity has resulted in some controversial aspects, including the level of pressure to be used. The level that has been used in very preterm infants after extubation, which mostly came from anecdotal data, varies from 3 to 10 cmH2O. Physiologic studies show higher nCPAP pressures improve lung mechanical properties. Though potential side effects have been of concern in practical application, there is no formal evidence supporting the concept that increased CPAP pressure results in a higher risk of complications. In relatively stable preterm infants, the range of optimal CPAP level needs to be established in order to adequately support the upper airway and lungs, without increasing complications secondary to the pressure applied. Given the uncertainty of the nCPAP pressure that should be used in very preterm infants, we conduct a randomized controlled trial to compare the effectiveness of two ranges of nCPAP pressure for post-extubation support in very preterm infants. The purpose of this trial is to compare the rate of successful extubation of using the nasal CPAP level of 7 to 9 cmH2O compared to level of 4 to 6 cmH2O.

Registry
clinicaltrials.gov
Start Date
July 2007
End Date
June 2010
Last Updated
17 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Birth weight 500 - 1,250 g
  • On mechanical ventilation before 7 days of age
  • First extubation before 14 days of age

Exclusion Criteria

  • Presence of lethal anomalies or upper airway abnormalities
  • IVH, grade 3 or 4
  • Neuromuscular disorders
  • Receiving muscle relaxation at time of extubation
  • Congenital heart disease, except for PDA
  • GI problems resulting in a need to avoid gastric distension

Outcomes

Primary Outcomes

The rate of successful extubation within 72 hours of extubation

Time Frame: within 72 hours after extubation

Secondary Outcomes

  • The rate of successful extubation within 7 days of extubation(within 14 days after extubation)
  • Number of days on nCPAP(within 14 days after extubation)
  • Occurrence of air leak syndrome(within 14 days after extubation)
  • Occurrence of IVH grade 3 or 4(within 14 days after extubation)
  • Occurrence of traumatized nasal septum(within 14 days after extubation)

Similar Trials